Literature DB >> 1856293

Serum C-reactive protein and neopterin concentrations in patients with viral or bacterial infection.

A C Shaw1.   

Abstract

Serum C-reactive protein and neopterin concentrations were measured in samples taken at an early stage in different types of infection to see whether the combination of markers could contribute to the diagnosis of infection and help distinguish between bacterial and viral infections, tuberculosis, and infections due to "other" pathogens. Both markers were significantly raised in all categories of infection compared with controls, and there were significant differences between the means of both markers when comparing several of the categories of infection. Only C-reactive protein concentrations in bacteraemic patients, however, were both sensitive and specific at distinguishing the type of infection. The additional use of neopterin estimation played only a minor part in increasing the specificity of diagnosis in tuberculosis and in viral infections. On the basis of this study it was not considered worth the time and expense of performing neopterin assays in addition to C-reactive protein estimations to differentiate viral from bacterial infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1856293      PMCID: PMC496802          DOI: 10.1136/jcp.44.7.596

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

Review 1.  Neopterin as a marker for activated cell-mediated immunity: application in HIV infection.

Authors:  D Fuchs; A Hausen; G Reibnegger; E R Werner; M P Dierich; H Wachter
Journal:  Immunol Today       Date:  1988-05

2.  The assessment of rheumatoid arthritis. A study based on measurements of the serum acute-phase reactants.

Authors:  B McConkey; R A Crockson; A P Crockson
Journal:  Q J Med       Date:  1972-04

3.  C reactive protein concentration as screening test for bacterial infection in febrile children.

Authors:  F B McCord; J G Jenkins; J H Lim
Journal:  Br Med J (Clin Res Ed)       Date:  1985-12-14

4.  Neopterin as an index of immune response in patients with tuberculosis.

Authors:  D Fuchs; A Hausen; M Kofler; H Kosanowski; G Reibnegger; H Wachter
Journal:  Lung       Date:  1984       Impact factor: 2.584

5.  The value of C-reactive protein as a marker of bacterial infection in patients with septicaemia/endocarditis and influenza.

Authors:  S Lindbäck; U Hellgren; I Julander; L O Hansson
Journal:  Scand J Infect Dis       Date:  1989

6.  Serum levels of C-reactive protein in patients with pulmonary tuberculosis and malignant tumors of the chest.

Authors:  P Maasilta; A A Kostiala
Journal:  Infection       Date:  1989 Jan-Feb       Impact factor: 3.553

7.  C-reactive protein fifty years on.

Authors:  M B Pepys
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

8.  Rapidity of C-reactive protein in detecting potential septicemia.

Authors:  H Peltola; C Holmberg
Journal:  Pediatr Infect Dis       Date:  1983 Sep-Oct

9.  D-erythro-neopterin plasma levels in intensive care patients with and without septic complications.

Authors:  W Strohmaier; H Redl; G Schlag; D Inthorn
Journal:  Crit Care Med       Date:  1987-08       Impact factor: 7.598

10.  C-reactive protein in patients with bacteremia.

Authors:  R E McCabe; J S Remington
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

View more
  11 in total

1.  A non-specific biomarker of disease activity in HIV/AIDS patients from resource-limited environments.

Authors:  Priyesh Bipath; Peter Levay; Steve Olorunju; Margaretha Viljoen
Journal:  Afr Health Sci       Date:  2015-06       Impact factor: 0.927

2.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

3.  Comparison of novel and familiar commercial kits for detection of C-reactive protein levels.

Authors:  Ihsan Hakkı Ciftci; Mehmet Koroglu; Engin Karakece
Journal:  World J Microbiol Biotechnol       Date:  2014-05-10       Impact factor: 3.312

4.  Value of serum C-reactive protein measurement in the detection of hepatocellular carcinoma superimposed on liver cirrhosis.

Authors:  C Fabris; M Pirisi; G Soardo; E Falleti; F Pezzetta; D Vitulli; P Toniutto; N Bortolotti; F Gonano; E Bartoli
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

5.  The importance of sonography in the diagnosis of septic complications following spinal surgery.

Authors:  A Korge; R Fischer; P Kluger; W Puhl
Journal:  Eur Spine J       Date:  1994       Impact factor: 3.134

6.  B-Type Natriuretic Peptide: A Predictor for Mortality, Intensive Care Unit Length of Stay, and Hospital Length of Stay in Patients With Resolving Sepsis.

Authors:  Harsimar Singh; Daryl Ramai; Harshil Patel; Marina Iskandir; Sarina Sachdev; Rabjot Rai; Jay Patolia; Getaw Worku Hassen
Journal:  Cardiol Res       Date:  2017-12-22

7.  Hyperferritinemia as a Diagnostic Marker for Severe Fever with Thrombocytopenia Syndrome.

Authors:  Uh Jin Kim; Tae Hoon Oh; Bansuk Kim; Seong Eun Kim; Seung-Ji Kang; Kyung-Hwa Park; Sook-In Jung; Hee-Chang Jang
Journal:  Dis Markers       Date:  2017-02-28       Impact factor: 3.434

8.  The effect of staphylococcal mastitis including resistant strains on serum procalcitonin, neopterin, acute phase response and stress biomarkers in Holstein dairy cows.

Authors:  Wael El-Deeb; Mahmoud Fayez; Naser Alhumam; Ibrahim Elsohaby; Sayed A Quadri; Hermine Mkrtchyan
Journal:  PeerJ       Date:  2021-05-31       Impact factor: 2.984

Review 9.  Conventional, molecular methods and biomarkers molecules in detection of septicemia.

Authors:  Mohammad Reza Arabestani; Sahar Rastiany; Sima Kazemi; Seyed Masoud Mousavi
Journal:  Adv Biomed Res       Date:  2015-06-04

Review 10.  Biomarkers for Sepsis: What Is and What Might Be?

Authors:  Bethany M Biron; Alfred Ayala; Joanne L Lomas-Neira
Journal:  Biomark Insights       Date:  2015-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.